Paradromics has named William J. Marks chief clinical officer; he brings nearly three decades of experience in clinical neuroscience and implantable devices. The appointment comes as the company advances Connect-One, an early feasibility study of its Connexus BCI system, which is intended to restore communication for people who have lost it to spinal cord injury, stroke or ALS.
